A new ESC clinical statement finds that common vaccines, including those for influenza and COVID-19, may lower cardiovascular risks such as heart attack, stroke, and heart failure, particularly in high-risk patients.
New research using US national survey data found that most adults with high LDL cholesterol are not receiving recommended treatments, and fully following clinical guidelines could prevent hundreds of thousands of cardiovascular events and reduce healthcare costs by billions annually.
A 40-week trial presented at ADA's 85th Scientific Sessions showed that daily oral orforglipron significantly lowered blood sugar and body weight in adults with early type 2 diabetes.
Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.
A new systematic review and meta-analysis found that cannabis use is associated with an increased risk of major adverse cardiovascular events—including acute coronary syndrome, stroke, and cardiovascular death—based on data from more than 432 million individuals in 24 observational studies.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
A secondary analysis of the EMPACT-MI trial, published in Nature Cardiovascular Research, shows that the sodium-glucose cotransporter-2 (SGLT2) inhibitor empagliflozin stabilizes kidney function and reduces heart failure hospitalizations in patients who have recently experienced a heart attack.
New study published in the International Journal of Epidemiology challenges the notion that standing reduces cardiovascular disease risk and suggests promoting overall physical activity for heart health. #CardiovascularHealth
Total apoB particle count and Lp(a) levels best reflect coronary artery disease risk, with researchers noting that lipid-related atherosclerotic risk is most accurately reflected by the total count of apoB-P.